What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »Could a Saliva Test Replace the Glucose Drink in Pregnancy? The Science Isn’t There Yet
Can saliva tests detect gestational diabetes? Explore promising salivary biomarkers, new research findings, and why blood tests remain essential.
Read More »Metformin Before the ICU: A Surprising Kidney Signal Challenges the Usual Narrative
A new ICU study links prior metformin use to lower odds of acute kidney injury. Explore the findings, limitations, and implications for diabetes care.
Read More »The Symptoms Were There: Why Was Type 1 Diabetes Still Missed?
Discover why type 1 diabetes symptoms are often missed in children, how diagnostic delays increase DKA risk, and what clinicians can do to improve detection.
Read More »Good Care, Bigger Bills: The Hidden Cost of High-Deductible Diabetes Plans
Learn why high-deductible health plans increase out-of-pocket costs for diabetes care and what these expenses mean for patients and providers.
Read More »A New DME Drug Matched Anti-VEGF on Vision: Could Retina Care Be Ready for a New Option?
Discover how remigromig performed against anti-VEGF therapy in the BRUNELLO trial and what AAO 2026 findings mean for diabetic macular edema care.
Read More »The Immune Target Moved, but the Diabetes Didn’t: What a Failed Type 1 Trial Can Teach Us
Interleukin-2 boosted immune cells but failed to preserve insulin production in the DIABIL-2 trial. Discover what this means for type 1 diabetes.
Read More »Diabetes Hospitalizations Aren’t Just About Heart and Kidney Disease Anymore
Explore why diabetes hospitalizations involve more than heart and kidney disease, including infections, respiratory illness, and mental health.
Read More »High-Fiber Diet vs. Metformin: A Small Trial Delivers a Surprising Result
A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.